vs
Side-by-side financial comparison of COMERICA INC (CMA) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
COMERICA INC is the larger business by last-quarter revenue ($838.0M vs $493.8M, roughly 1.7× Pediatrix Medical Group, Inc.). COMERICA INC runs the higher net margin — 21.0% vs 6.8%, a 14.2% gap on every dollar of revenue. On growth, COMERICA INC posted the faster year-over-year revenue change (3.3% vs -1.7%). Over the past eight quarters, COMERICA INC's revenue compounded faster (108.9% CAGR vs -0.1%).
Comerica Incorporated is an American financial services company, headquartered in Dallas, Texas. It is the parent of Comerica Bank, a regional commercial bank with 413 branches in the U.S. states of Texas, Michigan, California, Florida and Arizona. Comerica is among the largest U.S. financial holding companies, with offices in a number of U.S. cities.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
CMA vs MD — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $838.0M | $493.8M |
| Net Profit | $176.0M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | — | 9.9% |
| Net Margin | 21.0% | 6.8% |
| Revenue YoY | 3.3% | -1.7% |
| Net Profit YoY | -4.3% | 10.5% |
| EPS (diluted) | $1.35 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $493.8M | ||
| Q3 25 | $838.0M | $492.9M | ||
| Q2 25 | $849.0M | $468.8M | ||
| Q1 25 | $829.0M | $458.4M | ||
| Q4 24 | $825.0M | $502.4M | ||
| Q3 24 | $811.0M | $511.2M | ||
| Q2 24 | $824.0M | $504.3M | ||
| Q1 24 | $784.0M | $495.1M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | $176.0M | $71.7M | ||
| Q2 25 | $199.0M | $39.3M | ||
| Q1 25 | $172.0M | $20.7M | ||
| Q4 24 | $170.0M | $30.5M | ||
| Q3 24 | $184.0M | $19.4M | ||
| Q2 24 | $206.0M | $-153.0M | ||
| Q1 24 | $138.0M | $4.0M |
| Q4 25 | — | 9.9% | ||
| Q3 25 | — | 13.8% | ||
| Q2 25 | — | 12.8% | ||
| Q1 25 | — | 7.0% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | — | -31.3% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | — | 6.8% | ||
| Q3 25 | 21.0% | 14.5% | ||
| Q2 25 | 23.4% | 8.4% | ||
| Q1 25 | 20.7% | 4.5% | ||
| Q4 24 | 20.6% | 6.1% | ||
| Q3 24 | 22.7% | 3.8% | ||
| Q2 24 | 25.0% | -30.3% | ||
| Q1 24 | 17.6% | 0.8% |
| Q4 25 | — | $0.40 | ||
| Q3 25 | $1.35 | $0.84 | ||
| Q2 25 | $1.42 | $0.46 | ||
| Q1 25 | $1.25 | $0.24 | ||
| Q4 24 | $1.22 | $0.37 | ||
| Q3 24 | $1.33 | $0.23 | ||
| Q2 24 | $1.49 | $-1.84 | ||
| Q1 24 | $0.98 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $375.2M |
| Total DebtLower is stronger | $5.4B | $570.5M |
| Stockholders' EquityBook value | $7.4B | $865.9M |
| Total Assets | $77.4B | $2.2B |
| Debt / EquityLower = less leverage | 0.73× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $375.2M | ||
| Q3 25 | — | $340.1M | ||
| Q2 25 | — | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | $5.4B | $577.2M | ||
| Q2 25 | $5.8B | $583.9M | ||
| Q1 25 | $5.7B | $590.5M | ||
| Q4 24 | $6.7B | $597.1M | ||
| Q3 24 | $6.8B | — | ||
| Q2 24 | $7.1B | — | ||
| Q1 24 | $7.1B | — |
| Q4 25 | — | $865.9M | ||
| Q3 25 | $7.4B | $890.7M | ||
| Q2 25 | $6.9B | $833.8M | ||
| Q1 25 | $7.1B | $789.2M | ||
| Q4 24 | $6.5B | $764.9M | ||
| Q3 24 | $7.4B | $732.5M | ||
| Q2 24 | $6.2B | $706.5M | ||
| Q1 24 | $6.0B | $856.2M |
| Q4 25 | — | $2.2B | ||
| Q3 25 | $77.4B | $2.2B | ||
| Q2 25 | $78.0B | $2.1B | ||
| Q1 25 | $77.6B | $2.0B | ||
| Q4 24 | $79.3B | $2.2B | ||
| Q3 24 | $79.7B | $2.1B | ||
| Q2 24 | $79.6B | $2.0B | ||
| Q1 24 | $79.4B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | 0.73× | 0.65× | ||
| Q2 25 | 0.84× | 0.70× | ||
| Q1 25 | 0.81× | 0.75× | ||
| Q4 24 | 1.02× | 0.78× | ||
| Q3 24 | 0.92× | — | ||
| Q2 24 | 1.15× | — | ||
| Q1 24 | 1.18× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-270.0M | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -1.53× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $114.1M | ||
| Q3 25 | $-270.0M | $137.3M | ||
| Q2 25 | $476.0M | $137.2M | ||
| Q1 25 | $273.0M | $-117.5M | ||
| Q4 24 | $601.0M | $133.0M | ||
| Q3 24 | $1.0B | $91.8M | ||
| Q2 24 | $111.0M | $107.0M | ||
| Q1 24 | $-205.0M | $-125.2M |
| Q4 25 | — | 3.39× | ||
| Q3 25 | -1.53× | 1.91× | ||
| Q2 25 | 2.39× | 3.49× | ||
| Q1 25 | 1.59× | -5.66× | ||
| Q4 24 | 3.54× | 4.36× | ||
| Q3 24 | 5.70× | 4.72× | ||
| Q2 24 | 0.54× | — | ||
| Q1 24 | -1.49× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMA
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
